These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33996411)

  • 1.
    Martínez-López AL; González-Navarro CJ; Aranaz P; Vizmanos JL; Irache JM
    Acta Pharm Sin B; 2021 Apr; 11(4):989-1002. PubMed ID: 33996411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans.
    Martínez-López AL; González-Navarro CJ; Vizmanos JL; Irache JM
    Drug Deliv Transl Res; 2021 Apr; 11(2):647-658. PubMed ID: 33515186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery.
    Reboredo C; González-Navarro CJ; Martínez-López AL; Martínez-Ohárriz C; Sarmento B; Irache JM
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes.
    Reboredo C; González-Navarro CJ; Martínez-Oharriz C; Martínez-López AL; Irache JM
    Int J Pharm; 2021 Mar; 597():120287. PubMed ID: 33524523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate.
    Inchaurraga L; Martínez-López AL; Abdulkarim M; Gumbleton M; Quincoces G; Peñuelas I; Martin-Arbella N; Irache JM
    Int J Pharm X; 2019 Dec; 1():100006. PubMed ID: 31517271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zein-based nanoparticles for the oral delivery of insulin.
    Inchaurraga L; Martínez-López AL; Martin-Arbella N; Irache JM
    Drug Deliv Transl Res; 2020 Dec; 10(6):1601-1611. PubMed ID: 32514704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
    Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
    Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
    Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab.
    Pangua C; Espuelas S; Martínez-Ohárriz MC; Vizmanos JL; Irache JM
    Drug Deliv Transl Res; 2024 May; 14(5):1189-1205. PubMed ID: 37880504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
    Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
    Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zein nanoparticles as oral carrier for mometasone furoate delivery.
    Zimath P; Pinto S; Dias S; Rafacho A; Sarmento B
    Drug Deliv Transl Res; 2023 Nov; 13(11):2948-2959. PubMed ID: 37208563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
    Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
    Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.